Empagliflozin (EMPA) Reduces Heart Failure Irrespective of Control of Blood Pressure (BP), Low Density Lipoprotein Cholesterol (LDL-C), and HbA1c

Fitchett, D; Mcknight, J; Lee, J; George, JT; Mattheus, M; Woerle, HJ; Inzucchi, SE

DIABETES, 2017; 66 ( ): A312

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索